Supplement
A first major cardiovascular event is defined as the JUPITER primary endpoint (non--fatal myocardial infarction, non--fatal stroke, hospitalization for unstable angina, arterial revascularization, or death from cardiovascular causes). There was no statistically significant evidence for heterogeneity of the effect of rosuvastatin across baseline categories of high--sensitivity troponin I (P--interaction =0.53) or B--type natriuretic peptide (P--interaction = 0.20). Relative risk estimates were adjusted for age, sex, race, hypertension, smoking, body mass index, total cholesterol, high--density lipoprotein cholesterol, family history of coronary heart disease, and high--sensitivity C--reactive protein at baseline. The summary estimate is for the 12,956 participants with an hsTnI measure available.
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